Trials / Sponsors / Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors Advanced Synovial Sarcoma | Phase 1 | 2021-08-17 |
| Active Not Recruiting | FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies Advanced Hematologic Malignancy, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2021-06-14 |
| Terminated | FHD-286 in Subjects With Metastatic Uveal Melanoma Metastatic Uveal Melanoma | Phase 1 | 2021-05-11 |